Skip to content
Search

Latest Stories

Innovation trends see 'movement towards Asia' as pandemic hits global funding

THE coronavirus pandemic is expected to take a heavy toll on funding for innovation, and may well accelerate the shift in research towards Asia, the United Nations said on Wednesday (2).

"The great risk... is that innovation expenditures and the means to finance innovation will spiral downwards as the global economy grinds to something of a halt," Francis Gurry, the head of the UN's World Intellectual Property Organization (WIPO), told reporters in a virtual briefing.


He said no figures were available yet on the impact the pandemic was having on research and development spending, but there were clear indications that "money to fund innovation is drying up around the world".

The impact will be felt very unevenly, he said.

Fresh start-ups and start-up companies requiring long-term research and development investment, or based in developing countries, were likely to suffer the worst.

"This is not a very good scene at all," Gurry said.

He called on governments to broaden their support, urging them to recognise that innovative and new ideas will be vital to exiting the pandemic, and recovering through the post-Covid-19 era.

Gurry's comments came as the UN agency published its annual ranking of the world's most innovative countries, with Switzerland topping the list for the 10th year running.

But the data in the Global Innovation Index 2020, which WIPO compiles along with Cornell University and the INSEAD business school, was gathered before the onset of the pandemic.

'Eastward shift'

"We see that prior to the Covid-19 pandemic hitting, innovation and IP were flourishing," Gurry said, pointing out that global research and development spending in 2018 rose by 5.2 percent, far outperforming growth in global GDP.

The ranking closely resembled recent years' findings, with Sweden, the US, Britain and the Netherlands following Switzerland as the most innovative nations.

But while the data shows stability at the top, WIPO said it also clearly indicates that "a gradual eastward shift in the locus of innovation" is under way, with a group of Asian economies advancing up the rankings.

China, India, the Philippines and Vietnam have made the most progress on the index in recent years, with all four now among the top 50, it said.

China, which is the only middle-income economy among the top 30, is now in 14th place.

India has achieved impressive progress in rankings over the past five years. From rank 81 on the list in 2015, the country has now entered the top 50, moving up by four places last year to the 48th position.

"Thanks to universities such as the Indian Institute of Technology in Bombay and Delhi and the Indian Institute of Science in Bengaluru, and its top scientific publications, India is the lower middle-income economy with the highest innovation quality," noted the report.

Gurry acknowledged that it was difficult to know how the coronavirus crisis would impact innovation in different countries and regions.

But he said the pandemic overall appeared to be spurring an "acceleration of trends that were pre-existing", such as for instance, the virtualisation of economic activities.

"I would dare to make the very hesitant prediction that one of the trends that may be accelerated by the pandemic is indeed the movement towards Asia."

More For You

Shefali Jariwala

Glutathione and anti ageing drugs under spotlight after Shefali Jariwala death

Instagram/shefalijariwala

Did anti-ageing pills, beauty supplements and glutathione trigger Shefali Jariwala’s death?

Quick highlights:

  • Shefali Jariwala died at 42 in Mumbai after reportedly collapsing post-fast; cause of death suspected to be cardiac arrest or blood pressure drop.
  • Police found anti-ageing pills, vitamin supplements, and glutathione injections at her residence.
  • Doctors stress the risks of unsupervised use of hormone-based and anti-ageing treatments.
  • Final post-mortem report expected in two days; no foul play suspected, case treated as accidental death.

The untimely death of actor-model Shefali Jariwala has sparked renewed concern over the unregulated use of anti-ageing treatments and self-medication. The 42-year-old, best known for her appearance in Kaanta Laga, was declared dead on arrival at a Mumbai hospital on Friday night. Initial investigations suggest she may have suffered a cardiac arrest following a steep drop in blood pressure, possibly linked to taking supplements on an empty stomach.

Keep ReadingShow less
Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less